The Bas-Congo virus (BASV) and Heartland virus (HRTV) are both emerging pathogens that pose significant public health concerns. The Bas-Congo virus, discovered in the Democratic Republic of Congo, is associated with acute febrile illness, while the Heartland virus, identified in the United States, has been linked to tick-borne diseases affecting multiple organ systems. Early and accurate detection of these viruses is crucial for prompt patient management and the prevention of outbreaks.
The "Bas-Congo Virus and Heart Land Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a state-of-the-art diagnostic tool designed to identify and distinguish between the RNA of the Bas-Congo and Heartland viruses. This advanced test employs qualitative molecular techniques to detect the presence of viral RNA, enabling healthcare providers to accurately diagnose infections caused by either virus.
Performed at DNA Labs UAE, a leading facility in molecular diagnostics, this test offers a reliable solution for the early detection of these viruses. The cost of the test is set at 2310 AED, reflecting the sophisticated technology and expertise involved in conducting this specialized diagnostic assessment. By providing precise and timely identification of the Bas-Congo and Heartland viruses, this test plays a critical role in the effective management of affected patients and the prevention of potential epidemics.
The "Bordetella Multiplex Bordetella Toxin B.Pertussis B.Holmesii B.Parapertussis Detection and Differentiation RNA Detection Qualitative Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to accurately identify and differentiate between various Bordetella infections, including Bordetella pertussis, Bordetella holmesii, and Bordetella parapertussis. These pathogens are known for causing pertussis (whooping cough) and other respiratory conditions, which can be particularly severe in infants and those with compromised immune systems.
This test utilizes advanced RNA detection techniques to qualitatively analyze the presence of specific Bordetella species and the pertussis toxin gene. By targeting the RNA, the test ensures high sensitivity and specificity, providing reliable results that are crucial for the appropriate clinical management of patients.
The cost of the test is set at 2310 AED, reflecting the comprehensive nature of the analysis and the advanced technology employed. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is a valuable resource for healthcare providers in diagnosing and treating infections caused by Bordetella species, enabling tailored treatment plans and contributing to better patient outcomes.
The "Chlamydia Trachomatis, N. Gonorrhoeae, M. Genitalium Multiplex Detection and Differentiation RNA Detection Qualitative Test" is a sophisticated diagnostic tool offered by DNA Labs UAE, designed to accurately identify and differentiate between infections caused by Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium. These pathogens are responsible for some of the most common sexually transmitted infections (STIs) worldwide, each presenting with similar symptoms but requiring specific treatment approaches.
This test employs advanced RNA detection techniques to qualitatively assess the presence of these pathogens in a single sample. By targeting the unique genetic material (RNA) of each microorganism, the test provides a highly sensitive and specific diagnosis, enabling healthcare providers to tailor treatment strategies effectively.
The cost of the test is 2310 AED, reflecting the advanced technology and expertise required to perform this multiplex detection. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test is an invaluable resource for clinicians in the accurate diagnosis and management of these prevalent STIs, ultimately contributing to better patient outcomes and public health.
The "HCV Genotyping 1234 RNA Detection Qualitative Test" is a highly specific diagnostic procedure conducted to identify the genotype of the Hepatitis C virus (HCV) present in an individual's blood. This test is crucial for determining the specific genotype of HCV, as this information significantly influences the choice of treatment regimen. Hepatitis C virus has several genotypes, with 1 through 4 being the most common. Each genotype responds differently to treatment; hence, accurate determination through this test can lead to a more tailored and effective therapeutic approach.
The test employs sophisticated RNA detection techniques to qualitatively assess the presence of HCV genotypes 1, 2, 3, and 4. It is a vital tool in the management and treatment planning for individuals diagnosed with HCV, providing insights that guide healthcare professionals in selecting the most appropriate antiviral therapy.
Conducted at DNA Labs UAE, a facility renowned for its advanced diagnostic technologies and expertise in genetic and viral analysis, the test ensures high accuracy and reliability. The cost of the HCV Genotyping 1234 RNA Detection Qualitative Test at DNA Labs UAE is set at 2310 AED, reflecting the comprehensive and specialized nature of this diagnostic assessment. This investment is crucial for individuals with HCV, as it paves the way for a targeted treatment approach, potentially enhancing the effectiveness of therapy and improving patient outcomes.
The H3N2 and Influenza Group A Viral Load Quantitative Test is a precise diagnostic tool used to detect and quantify the presence of the H3N2 virus and other Influenza Group A viruses in a patient's sample. H3N2 is a subtype of the influenza virus that can cause severe respiratory illness, especially in the elderly and young children. Influenza Group A viruses are responsible for seasonal flu epidemics each year and can lead to significant morbidity and mortality worldwide.
This test is particularly useful for clinicians in managing and treating patients, especially during flu seasons or outbreaks, by allowing them to determine the viral load. A higher viral load can be associated with more severe symptoms and a higher risk of transmission. Knowing the exact viral load helps healthcare providers to tailor treatment strategies more effectively, potentially including antiviral medications.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic techniques and accuracy, the test is available for 2310 AED. DNA Labs UAE employs state-of-the-art technology to ensure reliable results, making it a trusted choice for patients and healthcare providers seeking to diagnose and manage influenza infections accurately.
The H7N2 and Influenza A Viral Load Quantitative Test is a specialized diagnostic procedure aimed at detecting and quantifying the presence of the H7N2 strain, alongside other Influenza A virus subtypes, within a patient's sample. This test is particularly crucial in the identification and management of infections caused by the H7N2 virus, a subtype of the Influenza A virus known for causing respiratory illness in humans and animals. The quantitative aspect of this test allows healthcare providers to measure the amount of virus in the body, which can be essential for assessing the severity of the infection and tailoring appropriate treatment strategies.
Conducted at DNA Labs UAE, a leading facility in medical diagnostics, the test leverages state-of-the-art technology to ensure accurate and reliable results. The cost of the test is set at 2310 AED, reflecting the intricate processes and sophisticated equipment involved in the detection and quantification of the virus. By offering this test, DNA Labs UAE plays a pivotal role in the early detection and effective management of H7N2 and Influenza A infections, contributing to better patient outcomes and public health surveillance.
The H7N7 and Influenza A Viral Load Quantitative Test is a specialized diagnostic procedure aimed at detecting and quantifying the presence of the H7N7 strain, alongside other Influenza A viruses, within a patient's sample. This advanced molecular test is crucial for the timely and accurate diagnosis of infections caused by these viruses, which are known for their potential to cause severe respiratory illnesses and, in some cases, outbreaks or pandemics.
Performed at DNA Labs UAE, a leading facility in the field of genetic and virological diagnostics, this test employs state-of-the-art technology to ensure high sensitivity and specificity. The process involves the extraction of viral RNA, followed by its amplification and quantification through Real-Time PCR (Polymerase Chain Reaction) techniques. This not only confirms the presence of the virus but also provides vital information on the viral load, which is essential for assessing the severity of the infection and guiding treatment decisions.
The cost of the H7N7 and Influenza A Viral Load Quantitative Test at DNA Labs UAE is set at 2310 AED. While the price may seem steep, it reflects the sophisticated nature of the testing methodology and the invaluable insights it offers into the management of infections caused by these potentially dangerous viruses. For patients and healthcare providers, this test represents a critical tool in the timely diagnosis and effective management of H7N7 and Influenza A virus infections.
The "DMD BMD Mutation Screening 26 Exons Prenatal Test" is a specialized genetic test offered by DNA Labs UAE, designed to screen for mutations in 26 specific exons of the DMD gene, which are crucial for diagnosing Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). These conditions are inherited disorders characterized by progressive muscle degeneration and weakness, with DMD presenting more severe symptoms than BMD. Early detection through prenatal testing is vital for families with a history of these disorders, as it can provide essential information for medical management and planning. The test is priced at 2100 AED, reflecting the advanced technology and expertise required to accurately identify the presence of mutations in these critical regions of the DMD gene. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, this test offers expectant parents peace of mind and the opportunity to prepare for the needs of their child.
The Epidermal Growth Factor Receptor (EGFR) Mutation Analysis, specifically targeting Exons 18, 19, 20, and 21, is a sophisticated diagnostic test offered by DNA Labs UAE. Priced at 2100 AED, this test is designed to identify mutations within the EGFR gene, which can be crucial for the diagnosis and treatment planning of various cancers, most notably non-small cell lung cancer (NSCLC).
EGFR is a protein on the surface of cells that, when mutated, can promote the growth of cancer cells. Mutations in specific exons, namely 18, 19, 20, and 21, are known to influence the effectiveness of targeted therapy regimens. By detecting these mutations, healthcare providers can tailor treatment strategies to better suit the genetic profile of the tumor, potentially improving patient outcomes.
The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results. It represents a critical step in the personalized medicine approach, allowing for more precise, targeted cancer therapy.
The Hepatitis B Virus (HBV) Genotype Test is a crucial diagnostic tool offered by DNA Labs UAE, designed to identify the specific genotype of the hepatitis B virus present in an individual's blood. This test is essential for guiding the treatment plan and predicting the course of the infection, as different genotypes can affect the severity of the disease, response to treatment, and the likelihood of developing liver complications such as cirrhosis or liver cancer.
Priced at 2100 AED, the HBV Genotype Test involves analyzing the patient's blood sample to detect the genetic material of the virus. By determining the genotype, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes. This test is recommended for individuals diagnosed with hepatitis B, especially those about to commence antiviral therapy, as it provides critical information that can influence the choice of medication and treatment duration.
DNA Labs UAE is equipped with state-of-the-art facilities and employs advanced technologies to ensure accurate and reliable test results. The lab's commitment to providing high-quality diagnostic services makes it a trusted choice for patients and healthcare professionals alike seeking comprehensive hepatitis B virus testing and analysis.
